Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database - Wikidata - wikimedia - TriplyDB

Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database

Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database

http://www.wikidata.org/entity/Q33388213

about

Immune thrombocytopenia Contemporary management of primary immune thrombocytopenia in adults Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis.Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.Ischemic stroke associated with immune thrombocytopenia.ITP: a historical perspective.Platelet activation and function during eltrombopag treatment in immune thrombocytopenia.What's new in the management of chronic primary immune thrombocytopenia in adults and the use of thrombopoietin receptor agonists.Immune thrombocytopenia: no longer 'idiopathic'.Eltrombopag for the treatment of immune thrombocytopenia.The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies.Ischemic stroke in the setting of chronic immune thrombocytopenia in an elderly patient--a therapeutic dilemma.Prevalence of diagnosed adult immune thrombocytopenia in the United Kingdom.In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation.Management of myocardial infarction in immune thrombocytopenic purpura with anti-phospholipid antibodies.Coronary artery stenting in a patient with chronic immune thrombocytopenic purpura: a clinical conundrum.Adverse postoperative outcomes in surgical patients with immune thrombocytopenia.Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies.Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile.The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia.Alternate considerations for current concepts in ITP.The biology of thrombopoietin and thrombopoietin receptor agonists.Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.Contemporary treatment of immune thrombocytopenia.Effect of steroids on the activation status of platelets in patients with Immune thrombocytopenia (ITP).Ischemic stroke associated with immune thrombocytopenia: lesion patterns and characteristics.Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.A Seeming Paradox: Ischemic Stroke in the Context of Idiopathic Thrombocytopenic Purpura.Thrombophilia in patients with chronic immune thrombocytopenia.Thrombopoiesis-stimulating agents and myelodysplastic syndromes.Fatigue in immune thrombocytopenia.Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim.Drug-Immune Thrombocytopenia with Thrombosis versus Heparin-Induced Thrombocytopenia: A Critical Clinical Controversy.Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥ 65 years with immune thrombocytopenia.Immune thrombocytopenic purpurae presenting with cortical vein thrombosis: is it rebalanced hemostasis?Is ITP a thrombophilic disorder?Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies.Cytokine-induced killer cell therapy-associated idiopathic thrombocytopenic purpura: rare but noteworthy.Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia.Procoagulant profile in patients with immune thrombocytopenia.

P2860

Q26830918-73AD418A-AD59-47DB-AAA0-52EBECF4DA89 Q26853680-D4B1D7D5-9144-422B-9653-06F28BB7B713 Q30250259-A49B136A-FAA7-4FD8-B57B-07B57B253C2D Q30399669-A888CF53-5DFA-4A48-BB25-7D67722FB81F Q30868478-B978A93B-35AB-413E-B0D4-C46D42355750 Q33394791-E6A47134-6840-4A0B-8D4E-9467D10F4CF7 Q33395231-2002F135-7701-4097-915C-7992838BF091 Q33395345-328B2432-5BD1-45D0-9CB8-E1BA1E68F0EB Q33395624-87ECF97B-5AAC-4404-99A5-CE53986ED572 Q33395776-F3FDF73B-9F0D-4D61-9968-DC2CB921445F Q33397768-8142B77D-D964-4AD8-8B73-3F17E2EFC8B8 Q33398252-BCD180C8-CF1D-4AB3-AE1E-E1854E5E14AA Q33398568-5CFD857E-8B95-43C6-8534-59CC5B0476B9 Q33399437-C3BCDFE4-115E-410A-A2A4-A0215CE4D50B Q33401971-740608F7-56D3-4979-B3D9-0E55CCEDB527 Q33403515-AF2F8A40-32BD-4448-97AC-9EDF4BAC3858 Q33405515-C3082727-C20E-4222-B619-F27652AE5C1C Q33406643-15129E14-58D7-4CA4-AB60-CCEFE2E03257 Q33406838-14248912-624B-4CB8-B6E3-C5C95D8D7F65 Q33407279-5CFF3EEC-3830-4D34-9156-18A487E69538 Q33407813-5D61BE00-C96C-4198-B1AE-FE00352CB2A1 Q33408850-8BF58DA4-073A-4644-86D4-590B07840EEC Q33409611-32AD128A-6EE5-424F-B8BF-79B94DF3CBF6 Q33410653-04C9672A-0B34-45FE-9AAC-EECBB20E722A Q33413853-1F766965-F3A8-48A1-968C-ABA1D7096413 Q33415633-4CBEBAB7-D0E6-48C7-93F0-762A4B287EBF Q33415996-5E97A7C5-14E7-4254-AD1C-57C3D7FC00A5 Q33417001-19849B90-60FB-4BA1-A279-B5BEB5F776D9 Q33418053-8BC8F93B-641F-43D2-AE0C-6A398CD1ACC8 Q33420207-8E5EEA5A-593C-4155-9491-E1249717B450 Q33421555-4ABF3BF5-BD9B-4F93-B3F1-A7EF2CF72B40 Q33424664-216DBE7E-CEC9-4081-A924-54A6C39BAFF4 Q33425127-D0539ABE-6D7D-41FF-96C6-7EEE61198FDF Q33425644-2140DC1F-5E24-490D-8CDF-6A1D4EA8256D Q33427390-848BDB94-6BFB-4CD8-B300-FD5A9B8730DC Q33427394-159F39CE-8D94-4F7B-A118-1C8D26893056 Q33431551-7A04E0A1-9573-4FA0-802E-16A1E1CF963C Q33434310-8765FB4C-B636-4546-9C03-FCE3599D07FC Q33434927-D8349E9D-2AA9-4D65-995C-BC353C4CD9FD Q33436189-D4A073EB-6AF4-4474-9ED7-5ACB5E6654DC

P2860

Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database

http://www.wikidata.org/entity/Q33388213

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Thromboembolic events among ad ...... ral Practice Research Database

@ast

Thromboembolic events among ad ...... ral Practice Research Database

@en

type

label

Thromboembolic events among ad ...... ral Practice Research Database

@ast

Thromboembolic events among ad ...... ral Practice Research Database

@en

prefLabel

Thromboembolic events among ad ...... ral Practice Research Database

@ast

Thromboembolic events among ad ...... ral Practice Research Database

@en

P1433

Q33388213-2DDCD24F-7718-4FC7-BCBC-72EB2489051E

P1476

Q33388213-98BFB6AC-8BC4-4094-9C57-14A5BAB099C6

P2093

Q33388213-06906A6E-812F-447F-9BD8-7DDB823901B1

Q33388213-1B804511-F03D-4AC2-ADB1-BA0AF19E5DFC

Q33388213-3C691310-254D-4F1A-A1DD-0F0B7A966604

Q33388213-A3B001A4-1A46-47AC-BC10-29E4C3EC6272

Q33388213-B1B5D8FD-51D7-4659-8AB4-D020031558A4

Q33388213-B3CAA9E6-82E6-4BAB-8C2F-5931EF9E0CD0

Q33388213-F99EF6BC-E7F5-4913-9C43-9F5E05888D84

Q33388213-FCCF7ACE-3AA2-40AE-BD2B-8ED5A4E2F3CA

P2860

Q33388213-0FBCCE34-7A33-47B4-B3E3-8B7D43297BA0

Q33388213-15B97AB5-B4D1-49D3-9621-A93560CDAEA9

Q33388213-193A73AB-B2FA-4500-8D9D-39C74B048410

Q33388213-273E2B04-44AD-4D2E-A7E2-CC2EE8142D55

Q33388213-2D968C13-4A46-47EE-9E07-0E55F07BBCD0

Q33388213-3F24DB62-8A0D-4534-9A70-FCE4EAADF449

Q33388213-42AD400F-667D-4C79-8635-05E6FC283977

Q33388213-4F367FBB-3284-44D2-BB74-BE814B5E69E4

Q33388213-5BA9E6D6-8A73-4C03-B721-97ECDD1D3211

Q33388213-76AE9B7B-E87C-4F98-85FE-4110EB56F675

P304

Q33388213-64C6AA9F-8317-4C8D-8FD0-11ED91E2E2E6

P31

Q33388213-FC57C38F-2E7B-4EE2-B9D7-18C94BA3F166

P356

Q33388213-54FBF43D-9F5F-4DB2-AE5A-38668F7C2C03

P433

Q33388213-2E59C7EF-54FC-47C5-A432-1E8EBE5CCB4F

P478

Q33388213-CA41D912-B16C-405C-A084-6D9290637CDD

P577

Q33388213-FD21CC86-6760-42B8-B21D-12BB007672E1

P5875

Q33388213-BD82AFCF-2E52-4176-AE59-BB534225EC1C

P698

Q33388213-62DF4EFA-79A9-4689-BFC2-14D32AE25FB2

P921

Q33388213-5D012CFF-9D39-42D9-9A41-6517FE451BE1

Q33388213-AB28AB59-5492-410D-AA37-13F5342C5766

P932

Q33388213-90DC1DD4-9D02-48DE-BD79-57B1FFA18300

P356

HAEMATOL.2009.018390

P1433

P1476

Thromboembolic events among ad ...... ral Practice Research Database

@en

P2093

Adrian C Newland

http://www.w3.org/2001/XMLSchema#string

Ameet Sarpatwari

http://www.w3.org/2001/XMLSchema#string

Amit Shukla

http://www.w3.org/2001/XMLSchema#string

Dimitri Bennett

http://www.w3.org/2001/XMLSchema#string

Drew Provan

http://www.w3.org/2001/XMLSchema#string

John W Logie

http://www.w3.org/2001/XMLSchema#string

Kathleen J Beach

http://www.w3.org/2001/XMLSchema#string

Simon Sanderson

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of immune thrombocytopenia: analyses of administrative data.

The incidence of idiopathic thrombocytopenic purpura in adults increases with age.

Morbidity and mortality in adults with idiopathic thrombocytopenic purpura.

Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study.

Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy.

Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro.

Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients.

Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP.

Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies.

The effect of antiplatelet autoantibodies on megakaryocytopoiesis.

P304

1167-1175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2009.018390

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41419662

http://www.w3.org/2001/XMLSchema#string

P698

20145266

http://www.w3.org/2001/XMLSchema#string

P921

thromboembolism

thrombocytopenia

P932

2895042

http://www.w3.org/2001/XMLSchema#string